The USPTO awarded Quadrant Biosciences with U.S. Patent No.11,453,914 for the analysis and prediction of mild traumatic brain injury.
The device blends enhanced slow-flow rates with precision dispensing for increased application flexibility across a wide volume range.Read More
Candidates have demonstrated comparable preclinical efficacy to existing anticoagulants but with substantially lower bleeding liability.Read More
The DiscoveryMap platform from Myriad RBM has identified combinations of 15 protein biomarkers associated with cardiovascular events in patients with diabetes.Read More
Researchers seek to better understand the genomic basis of disease, and provide tailored care to patients.Read More
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.Read More
The concept of prevention is expanding, notes principal investigator Christie Ballantyne, MD, director of the Center for Cardiovascular Disease Prevention at The Methodist Hospital.Read More